As part of our research group on Tumor Resistance to Treatment (TumHyp), we are investigating the molecular mechanisms underlying cancer cells' resistance to chemotherapy, radiation therapy, and immunotherapy.
Project Leader (PI) | Carine Michiels
Carine Michiels is a full professor at the University of Namur and a member of the Narilis Institute.
View Carine Michiels' profile in the UNamur directory.
Research within the TumHyp Group
The TumHyp research group studies the mechanisms of tumor progression and resistance to chemotherapy, radiation therapy, and immunotherapy, with the goal of developing new strategies to overcome treatment resistance or recurrence. In this context, the group is investigating the role of various physical and cellular mechanisms of resistance and invasiveness, such as tumor hypoxia, cell death, senescence, inflammation, and the interaction of cancer cells with the tumor microenvironment.
Numerous studies have addressed the question of how to overcome the intrinsic or acquired resistance of cancer cells to radiation therapy. In this context, current research aims to identify the genes involved in the intrinsic resistance of glioblastoma to radiation therapy. In addition, the induction of cell death, senescence, and cell cycle arrest following radiation therapy is being studied in head and neck, pancreatic, and lung cancers. The use of charged-particle radiation therapy, either alone or in combination with gold nanoparticles or immunotherapy, to enhance the destruction of cancer cells, synthetic lethality, or to promote an inflammatory tumor microenvironment and an antitumor immune response, is of particular interest.
Current Research Programs
- Study of Glioblastoma Resistance to Temozolomide Combined with Radiation Therapy (X-rays vs. Protons): The Role of Extracellular Vesicles
- Unraveling the dynamic interaction between radiation-induced microenvironment senescence and tumor development in the context of soft tissue sarcoma
- Immunogenicity of cancer cells induced by radiation therapy
- Development of a personalized neutron-capture therapy using theranostic vectors
- Identification of genes involved in intrinsic resistance to temozolomide combined with proton therapy for the treatment of glioblastomas
- Study of the pro-senescence response to anticancer treatments in HPV-positive versus HPV-negative head and neck cancers
- Study of the radiosensitizing effect of gold nanoparticles
- Modulation of tumor-induced immunosuppression by proton therapy to enhance the effects of the PD-1 immune checkpoint inhibitor
- In vitro and in vivo study of the effects of FLASH proton therapy: from ferroptosis, oxidative stress, and senescence to endoplasmic reticulum and mitochondrial stress”
Our Publications
- The Oxygen Puzzle in FLASH Radiotherapy: A Comprehensive Review and Experimental Outlook. Scarmelotto A, Delprat V, Michiels C, Lucas S, Heuskin AC. Clin Transl Radiat Oncol. September 18, 2024;49:100860. doi: 10.1016/j.ctro.2024.100860. eCollection Nov. 2024. PMID: 39381632 Free PMC article.
- Indacaterol inhibits collective cell migration and IGDQ-mediated single-cell migration in metastatic breast cancer MDA-MB-231 cells. Ayama-Canden S, Tondo R, Pineros Leyton ML, Ninane N, Demazy C, Dieu M, Fattaccioli A, Sauvage A, Tabarrant T, Lucas S, Bonifazi D, Michiels C. Cell Commun Signal. Oct 30, 2023;21(1):301. doi: 10.1186/s12964-023-01340-9. PMID: 37904233 Free PMC article.
- IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells. Ayama-Canden S, Tondo R, Piñeros L, Ninane N, Demazy C, Dieu M, Fattaccioli A, Tabarrant T, Lucas S, Bonifazi D, Michiels C. Neoplasia. September 2022;31:100816.
doi: 10.1016/j.neo.2022.100816. Epub 2022 Jun 25. PMID: 35763908 Free PMC article. - Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263. Huart C, Fransolet M, Demazy C, Le Calvé B, Lucas S, Michiels C, Wéra AC. Cancers (Basel). March 12, 2022;14(6):1460. doi: 10.3390/cancers14061460. PMID: 35326611 Free PMC article.
- The impact of macrophages on endothelial cells is potentiated by cyclic hypoxia: Enhanced tumor inflammation and metastasis. Delprat V, Huart C, Feron O, Soncin F, Michiels C. Front Oncol. September 28, 2022;12:961753. doi: 10.3389/fonc.2022.961753. eCollection 2022. PMID: 36248978 Free PMC article.
- Gold nanoparticles meet medical radionuclides. Daems N, Michiels C, Lucas S, Baatout S, Aerts A. Nucl Med Biol. Sep–Oct 2021;100–101:61–90.
doi: 10.1016/j.nucmedbio.2021.06.001. Epub 2021 Jun 15. PMID: 34237502 Free article. - A bidirectional dialogue between vascular cells and monocytes/macrophages regulates tumor progression. Delprat V, Michiels C. Cancer Metastasis Rev. 2021 Jun;40(2):477-500. doi: 10.1007/s10555-021-09958-2. Epub 2021 Mar 30. PMID: 33783686 Free PMC article.
- Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer? Huart C, Chen JW, Le Calvé B, Michiels C, Wéra AC. Int J Mol Sci. July 4, 2020;21(13):4767. doi: 10.3390/ijms21134767. PMID: 32635552 Free PMC article.
- Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient. Penninckx S, Heuskin AC, Michiels C, Lucas S. Cancers (Basel). July 23, 2020;12(8):2021. doi: 10.3390/cancers12082021. PMID: 32718058 Free PMC article.
- Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via the JNK/p65 signaling pathway. Delprat V, Tellier C, Demazy C, Raes M, Feron O, Michiels C. Sci Rep. 2020 Jan 21;10(1):882. doi: 10.1038/s41598-020-57677-5. PMID: 31964911 Free PMC article.
- Antibody-functionalized gold nanoparticles as tumor-targeting radiosensitizers for proton therapy. Li S, Bouchy S, Penninckx S, Marega R, Fichera O, Gallez B, Feron O, Martinive P, Heuskin AC, Michiels C, Lucas S. Nanomedicine (Lond). Feb 2019;14(3):317-333. doi: 10.2217/nnm-2018-0161. Epub Jan 24, 2019. PMID: 30675822
- Thioredoxin Reductase Activity Predicts the Radiosensitizing Effect of Gold Nanoparticles. Penninckx S, Heuskin AC, Michiels C, Lucas S. Nanomaterials (Basel). Feb 19, 2019;9(2):295. doi: 10.3390/nano9020295. PMID: 30791480 Free PMC article.
- Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation. Wéra AC, Lobbens A, Stoyanov M, Lucas S, Michiels C. Cell Cycle. Aug 2019;18(15):1770-1783. doi: 10.1080/15384101.2019.1632640. Epub 2019 Jun 25. PMID: 31238782 Free PMC article.
- Gold nanoparticles affect the antioxidant status in selected normal human cells. Daems N, Penninckx S, Nelissen I, Van Hoecke K, Cardinaels T, Baatout S, Michiels C, Lucas S, Aerts A. Int J Nanomedicine. July 8, 2019;14:4991-5015. doi: 10.2147/IJN.S203546. eCollection 2019. PMID: 31371943 Free PMC article.
- Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin. Schmit K, Chen JW, Ayama-Canden S, Fransolet M, Finet L, Demazy C, D'Hondt L, Graux C, Michiels C. Cell Death Dis. Dec 4, 2019;10(12):919. doi: 10.1038/s41419-019-2088-x. PMID: 31801939 Free PMC article.